Answer to Question 1
Correct Answer: 1
Rationale 1: RhoGAM is indicated for the pregnant client or one who is 72 hours post-delivery.
Rationale 2: RhoGAM is not an immunosuppressant for kidney transplant clients.
Rationale 3: RhoGAM does not fight HIV disease.
Rationale 4: RhoGAM does not enhance immunity in the immunosuppressed.
Global Rationale: The administration of RhoGAM is recommended at 28 weeks' gestation, within 72 hours postpartum, within 3 hours of spontaneous or induced pregnancy termination, and following any event that could lead to transplacental hemorrhage (such as amniocentesis, chorionic villi sampling, or abdominal trauma). RhoGAM is not an immunosuppressant, is not given to fight HIV, and does not enhance immunity in the immunosuppressed.
Answer to Question 2
Correct Answer: 1,3,5
Rationale 1: Antibodies are administered when the client is at great risk for exposure.
Rationale 2: If the initial immunization failed, it would be repeated.
Rationale 3: Antibodies are administered when the client has been exposed to virulent pathogens.
Rationale 4: Antibodies would not be given to bone marrow transplant clients.
Rationale 5: Antibodies are administered when there is insufficient time to develop active immunity.
Global Rationale: Passive immunization is typically used to provide immediate protection against a recent infection, a potential infection, or a disease in progress. If the initial immunization failed, it would be repeated. Antibodies would not be given to bone marrow transplant clients.
Critical thinking involves analysis in which the nurse examines patient data available from a variet
Client on IV patient-controlled analgesia (PCA).
B, The nurse teaches the postoperative client to use an incentive spirometer to expand the lungs.
Multiple-dose drug administration: drug A and drug B are administered every 12 hours; drug B reaches
Nurse opens sterile package